Despite facing geopolitical instability and weather-related challenges, India's economy is expected to grow robustly at 6.9% in FY27. This ...

Cummins India is aggressively investing in electric, fuel blending, and hydrogen technologies to secure growth beyond 2030 and counter risi...

Goldman Sachs has raised India's 2026 real GDP growth forecast to 6.8% from 6.5%, citing lower oil prices, easing supply disruptions and re...

India is working to expand its textile manufacturing base beyond traditional hubs such as Tirupur, Surat, Panipat and Ludhiana, by engaging...

Laurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...

US inflation climbed to 4.1% in May, driven by rising energy prices, keeping the Federal Reserve's interest rate hike plans on the table fo...

The growth in gross domestic product - the nation's output of goods and services - marked a rebound from a sluggish 0.5% in the last three ...

Indian consumer firms are significantly boosting investments in Africa, shifting from market entry to large-scale operations. Driven by a y...

Indian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...

Foreign institutional investors (FIIs) reversed their selling trend in six select Indian stocks, turning them into multibaggers. Bajaj Cons...

India's textile sector is poised for significant growth, driven by a global shift in sourcing away from China and a cyclical recovery in de...

India's private sector experienced a slowdown in June, reaching a three-month low as rising costs and softening demand impacted business. T...

US manufacturing activity surged in June as businesses stocked up anticipating shortages and price hikes, driven by Middle East conflict im...

India's economic outlook is brightening, with a top strategist predicting a multi-year manufacturing export boom. Despite past currency woe...

Corporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...

Aurobindo Pharma's US arm has secured Federal Trade Commission approval for its $250 million acquisition of Lannett Company. This strategic...

US factory production remained flat in May. This unexpected result followed a strong April. Output of long-lasting goods like vehicles rose...